NCT04877574

Brief Summary

This study evaluates the effects of Analgesia Nociception Index (ANI)-guided intraoperative analgesia on postoperative pain in patients undergoing open gynecologic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable postoperative-pain

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable postoperative-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 7, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 11, 2022

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2022

Completed
Last Updated

September 19, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

April 30, 2021

Last Update Submit

September 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of moderate-to-severe postoperative pain

    the incidence of moderate-to-severe postoperative pain is defined as a case in which pain with numeric rating scale (NRS) of 5 or more is reported during stays in the postanesthesia care unit. Pain assessment is performed two times during stays in the postanesthesia care unit.

    during 1 hour of stay in the postanesthesia care unit

Secondary Outcomes (4)

  • the amount of intraoperative remifentanil

    intraoperative

  • Quality of Recovery-15 (QoR-15) score

    at postoperative 24 hour

  • the incidence of postoperative nausea and vomiting

    at postoperative 1 hour, 24 hour, 72 hour

  • 11-pointed NRS pain score

    at postoperative 24 hour

Study Arms (2)

ANI-guided intraoperative analgesia

EXPERIMENTAL

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil to maintain 50-70 of ANI index.

Procedure: ANI-guided intraoperative analgesia

Conventional intraoperative analgesia

ACTIVE COMPARATOR

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil at the discretion of attending anesthesiologists based on hemodynamic parameters.

Procedure: Conventional intraoperative analgesia

Interventions

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil to maintain 50-70 of ANI.

ANI-guided intraoperative analgesia

Intraoperative analgesia is performed by controlling the effect-site concentration of remifentanil at the discretion of attending anesthesiologists based on hemodynamic parameters.

Conventional intraoperative analgesia

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • Elective open gynecological surgery
  • American Society of Anaesthesiologists physical status classification 1-3

You may not qualify if:

  • Laparoscopic surgery or robot-assisted surgery
  • Patients who had analgesic agents, anti-psychotic agents, anticonvulsants which were related to chronic pain
  • Patients who had hypersensitivity to analgesic agents or medications related anesthesia.
  • Patients who were required to have mechanical ventilation after surgery
  • Patients who had arrhythmia
  • Patients who transferred to the surgical intensive care unit immediately after surgery
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Hospital

Seoul, 03080, South Korea

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 30, 2021

First Posted

May 7, 2021

Study Start

July 1, 2021

Primary Completion

July 11, 2022

Study Completion

July 15, 2022

Last Updated

September 19, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations